Picture of ToolGen logo

199800 ToolGen Share Price

0.000.00%
kr flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Momentum

Relative Strength (%)
1m+3%
3m+13.18%
6m-1.87%
1yr+43.58%
Volume Change (%)
10d/3m-79.12%
Price vs... (%)
52w High-39.09%
50d MA+4.58%
200d MA+22.78%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)n/a
PEG Ratio (f)n/a
EPS Growth (f)n/a
Dividend Yield (f)n/a
Valuation (ttm)IndustryMarket
Price to Book Value20.73
Price to Tang. Book22.55
Price to Free Cashflown/a
Price to Sales494.08
EV to EBITDAn/a

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital-20.26%
Return on Equity-92.63%
Operating Margin-1654.74%

Financial Summary

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Dec 202431st Dec 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of ToolGen EPS forecast chart

Profile Summary

ToolGen, Inc. is principally engaged in the development of engineered nucleases. The Company’s main products portfolio consists of ribose nucleic acid (RNA)-guided endonucleases (RGEN) as well as deoxyribonucleic acid (DNA)-directed RGEN (dRGEN), which are applied as tools for editing genetic information in microbial, plant, animal and human cells. In addition, it is involved in the provision of genome engineering services.

Directors

Last Annual
December 31st, 2023
Last Interim
March 31st, 2024
Incorporated
October 8th, 1999
Public Since
June 25th, 2014
No. of Shareholders
19,360
No. of Employees
80
Sector
Biotechnology & Medical Research
Industry
Healthcare
Exchange
kr flag iconKorea Exchange - KOSDAQ
Shares in Issue
7,938,458
Blurred out image of a map
Address
SEOUL, 07789
Web
http://www.toolgen.com/
Phone
+82 28738168
Auditors
Shinhan Accounting Corporation

199800 Share Price Performance

Upcoming Events for 199800

Similar to 199800

Picture of ABion logo

ABion

kr flag iconKorea Exchange - KOSDAQ

Picture of ABL Bio logo

ABL Bio

kr flag iconKorea Exchange - KOSDAQ

Picture of ADM Korea logo

ADM Korea

kr flag iconKorea Exchange - KOSDAQ

Picture of Amicogen logo

Amicogen

kr flag iconKorea Exchange - KOSDAQ

Picture of AprilBio Co logo

AprilBio Co

kr flag iconKorea Exchange - KOSDAQ

FAQ